CD8A and neoplasm: To evaluate the functional contribution of tumor-infiltrating CD8+ T cells in the context of ORFV treatment, we depleted CD8+ T cells by administrating anti-CD8 blocking antibodies to B16 tumor-bearing mice, and observed that depletion of CD8+ T cells significantly reversed ORFV-induced tumor remission (Fig. 4f, g).